Showing results (141-150 of 181) with videos related to

Sort By:
Pageof 19
Urologic Oncology|April 1, 2017
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinomaGiuseppe Lucarelli, Monica Rutigliano, Matteo Ferro, et al.
World Journal of Urology|December 26, 2024
Oncological outcomes and prognostic implications of T1 histo-anatomic substaging in the management of high-Grade non-muscle invasive bladder cancer: results from a large single centre seriesMarco Finati, Antonio Fanelli, Francesco Cinelli, et al.
Histology and Histopathology|December 6, 2019
Role of androgen receptor expression in non-muscle-invasive bladder cancer: a systematic review and meta-analysisFrancesca Sanguedolce, Luigi Cormio, Giuseppe Carrieri, et al.
Cancers|July 2, 2021
T-Cell Lymphoblastic Lymphoma Arising in the Setting of Myeloid/Lymphoid Neoplasms with Eosinophilia: LMO2 Immunohistochemistry as a Potentially Useful Diagnostic MarkerMagda Zanelli, Giuseppe G Loscocco, Elena Sabattini, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Primary Vitreoretinal Lymphoma: Current Diagnostic Laboratory Tests and New Emerging Molecular ToolsBeatrice Melli, Pietro Gentile, Davide Nicoli, et al.
Journal of Personalized Medicine|December 24, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 7: PD-L1 Expression in Liquid BiopsyAndrea Palicelli, Martina Bonacini, Stefania Croci, et al.
Nucleic Acids Research|April 10, 2024
HELLS regulates transcription in T-cell lymphomas by reducing unscheduled R-loops and by facilitating RNAPII progressionAnnalisa Tameni, Selene Mallia, Veronica Manicardi, et al.
Frontiers in Oncology|June 7, 2021
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center StudySalvatore M Bruno, Ugo G Falagario, Nicola d'Altilia, et al.
Autophagy|September 23, 2015
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38Valentina Grossi, Giuseppe Lucarelli, Giovanna Forte, et al.
World Journal of Urology|March 27, 2023
Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?Gian Maria Busetto, Marco Finati, Marco Chirico, et al.
Pageof 19